Detalhe da pesquisa
1.
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.
Lab Invest
; 101(1): 26-37, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873880
2.
NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.
Int J Cancer
; 136(6): E590-601, 2015 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25081390
3.
ROS1 rearrangements in non-small cell lung cancer: screening by immunohistochemistry using proportion of cells staining without intensity and excluding cases with MAPK pathway drivers improves test performance.
Pathology
; 54(3): 279-285, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635319
4.
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.
Cancer Immunol Immunother
; 60(11): 1625-37, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21698545
5.
Distinctive localization of antigen-presenting cells in human lymph nodes.
Blood
; 113(6): 1257-67, 2009 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18987360
6.
Melan-A-specific cytotoxic T cells are associated with tumor regression and autoimmunity following treatment with anti-CTLA-4.
Clin Cancer Res
; 15(7): 2507-13, 2009 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19318477
7.
A Malignant Neoplasm From the Jejunum With a MALAT1-GLI1 Fusion and 26-Year Survival History.
Int J Surg Pathol
; 28(5): 553-562, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31931637
8.
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.
Cancer Immunol Immunother
; 58(10): 1635-46, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19221743
9.
ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.
Clin Cancer Res
; 14(11): 3291-8, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18519755
10.
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.
J Clin Invest
; 129(5): 1940-1945, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30835257
11.
Tumor antigen expression in melanoma varies according to antigen and stage.
Clin Cancer Res
; 12(3 Pt 1): 764-71, 2006 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16467087
12.
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvant.
Immunotherapy
; 9(3): 249-259, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183192
13.
Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.
Melanoma Res
; 16(4): 347-55, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16845331
14.
Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
Clin Cancer Res
; 10(24): 8396-404, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15623618
15.
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
Eur J Cancer
; 47(3): 460-9, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21115342
16.
The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.
Cancer Res
; 68(8): 3001-9, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18413770
17.
Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.
J Immunol
; 176(10): 5908-17, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16670298
18.
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
J Immunother
; 29(5): 499-511, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16971806